- Home
- PRPL vs CNTX Comparison
PRPL vs CNTX Comparison
Compare PRPL & CNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRPL
- CNTX
- Stock Information
- Founded
- PRPL 2010
- CNTX 2015
- Country
- PRPL United States
- CNTX United States
- Employees
- PRPL N/A
- CNTX N/A
- Industry
- PRPL Home Furnishings
- CNTX Biotechnology: Pharmaceutical Preparations
- Sector
- PRPL Consumer Discretionary
- CNTX Health Care
- Exchange
- PRPL Nasdaq
- CNTX Nasdaq
- Market Cap
- PRPL 78.9M
- CNTX 78.0M
- IPO Year
- PRPL N/A
- CNTX 2021
- Fundamental
- Price
- PRPL $0.90
- CNTX $0.84
- Analyst Decision
- PRPL Hold
- CNTX Strong Buy
- Analyst Count
- PRPL 2
- CNTX 5
- Target Price
- PRPL $1.25
- CNTX $5.50
- AVG Volume (30 Days)
- PRPL 1.1M
- CNTX 197.0K
- Earning Date
- PRPL 07-29-2025
- CNTX 08-06-2025
- Dividend Yield
- PRPL N/A
- CNTX N/A
- EPS Growth
- PRPL N/A
- CNTX N/A
- EPS
- PRPL N/A
- CNTX N/A
- Revenue
- PRPL $472,015,000.00
- CNTX N/A
- Revenue This Year
- PRPL N/A
- CNTX N/A
- Revenue Next Year
- PRPL $10.65
- CNTX N/A
- P/E Ratio
- PRPL N/A
- CNTX N/A
- Revenue Growth
- PRPL N/A
- CNTX N/A
- 52 Week Low
- PRPL $0.56
- CNTX $0.49
- 52 Week High
- PRPL $1.50
- CNTX $2.75
- Technical
- Relative Strength Index (RSI)
- PRPL 64.00
- CNTX 64.84
- Support Level
- PRPL $0.64
- CNTX $0.82
- Resistance Level
- PRPL $1.08
- CNTX $0.87
- Average True Range (ATR)
- PRPL 0.07
- CNTX 0.07
- MACD
- PRPL 0.02
- CNTX 0.01
- Stochastic Oscillator
- PRPL 58.14
- CNTX 58.27
About PRPL Purple Innovation Inc.
Purple Innovation Inc is a comfort innovation company. The company designs, manufactures and sells a range of comfort technology offerings, including mattresses, a pillow, cushions, sheets, bed platforms and other products. The Company has one reportable segment that operates an omni-channel distribution which allows the Company to offer a seamless shopping experience to its customers across multiple sales channels. It sells its products through its direct-to-consumer e-commerce channels, retail brick-and-mortar wholesale partners, Purple showrooms, and third-party online retailers.
About CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.